Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-040302 vs Control in Solitary Bone Cysts
NCT00459641Phase 2Withdrawn
- Sponsor
- Kuros Biosciences
- Start
- Dec 2012
- Primary completion
- Jun 2014
01
Overview
Phase 2, randomised, open-label trial in solitary bone cyst (SBC) comparing I-040302 with Standard of Care (2 arms). Primary endpoint: Radiographic images at 6 months. Planned start Dec 2012; status: withdrawn.
02
Drugs
I-040302
03
Conditions
solitary bone cyst (SBC)
Beyond the preview
Go deeper on NCT00459641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459641.